2012年10月17日星期三

Kobe Bryant helps out Alex Rodriguez

ANAHEIM, Calif. -- Kobe Bryant was busy scoring 31 points in 29 minutes of the Los Angeles Lakers' 114-80 exhibition loss to the Utah Jazz on Tuesday night at the Honda Center.

The New York Yankees' 2-1 loss to the Detroit Tigers in Game 3 of the American League Championship Series was a world away. But the struggles of his friend Alex Rodriguez were not.

"We spoke a couple of days ago," Bryant said of Rodriguez, whom he befriended on the set of a commercial a few years ago. "You can only control what you can control. You go out there and do the best job you can. If they take you out of the lineup, it's really on you to be a good teammate and support the other guys, which he's good about doing."
But that's not exactly what Bryant said when he called Rodriguez, who was benched for Game 3 on Tuesday night because he's hit .143 in the ALCS and .130 in the playoffs with no RBIs.
No, that conversation went more like this:
"I just say to him, 'You're Alex Rodriguez. You're A-Rod. You're one of the best to ever do it,'" Bryant said. "I think sometimes he kind of forgets that and wants to try to do the right thing all the time. Which is the right team attitude to have. But other times you really have to put your head down and say, 'Hell with it' and just do your thing.
"Hopefully the next game they'll kind of give him a chance, maybe put him back at third and let him respond to the pressure, which I think he'll do."
Although both are among the best to ever play their respective sports, Bryant and Rodriguez would seem to be very dissimilar.
"We're different," Bryant said. "But you're talking about, 'He's one of the best to ever play.' I think really the difference is, sometimes he forgets he's the best. ... Where, I don't."
Bryant laughed at the self-deprecating comment, then continued on to explain how the two men are in some ways the same.
"We know what it takes to get to that level," he said. "The consistency, the sacrifice, the work ethic, the constant scrutiny, that's something we all have in common -- from golf to cycling to swimming to basketball to baseball."


more interest:

Microsoft becomes friend and foe to PC partners

Chinese Scientist Says Prehistoric Man Ate Pandas

http://sweetlifeofbiguipeng.blogspot.com/


2012年10月15日星期一

Giant Florida eyeball belonged to a swordfish, state says




It looks like the big blue eyeball found on a Florida beachlast week was cut out of a swordfish hauled in by a deep-sea angler, the state Fish and Wildlife Conservation Commission said Monday.
A beachcomber found the softball-sized eyeball on the sand in Pompano Beach, Florida, on Wednesday, speculating that perhaps it came from a squid.
But experts who examined the eyeball made their call of swordfish based on the its size (softball), color (blue) and structure (presumably swordfishy), according to a statement from Joan Herrera, curator of collections at the agency's Fish and Wildlife Research Institute in St. Petersburg.
Based on straight cuts on the bone around the eyeball, Herrera said, experts think an angler cut it out of a swordfish and tossed it overboard.
The half-ton fish are frequently found in the Florida Straits off South Florida at this time of year, according to the statement.
DNA testing is being done to confirm the finding, the agency said。
more:

Mice Can ‘Sing’ and Learn Songs Just like Humans




And you thought those singing mice in Babe were just movie magic.
It turns out not only that mice can pour forth sweet music, but that they can lean new songs in different keys, reports the BBC. Instead of singing in three-part harmony, however, scientists have discovered that male mice housed together actually learn to sing in unison — on the same pitch.
It’s long been known that male mice serenade their ladies during courtship. But until now, it was believed that the little mammals were essentially a broken record; they couldn’t change the order or pitch of their piece. The new research, published in the journal Plos One, suggests that mice may indeed modify their melodies — a talent previously thought to be confined to songbirds, whales, dolphins, sea lions, bats, elephants and humans.
The researchers from Duke University also found that the mice are using the same part of their brain to vocalize that humans do. ”In mice we find that the pathways that are at least modulating these vocalisations are in the forebrain, in places where you actually find them in humans,” lead researcher Dr. Erich Jarvis told the BBC. Their skills, he says, are intermediate “between a chicken and a song bird or even a nonhuman primate and a human.”
So does this mean you’ll be able to hear (and perhaps hum along) to mouse music? Unfortunately not: their ultrasonic songs are inaudible to the human ear.
To listen to a recording of male mouse seductions songs modified so humans can listen in, pop on over to the BBC.


Read more: http://newunknownboss.blogspot.com/2012/10/canadian-cousins-alert-justin-bieber.html

2012年10月11日星期四

Fungal Meningitis Outbreak: 170 Cases, 14 Deaths


Two more people have died from fungal meningitis linked to tainted steroid injections, raising the death toll for the outbreak to 14.

The U.S. Centers for Disease Control and Prevention today reported that 169 people in 11 states have contracted fungal meningitis after receiving spinal injections of methylprednisolone acetate for back pain. One person has contracted a joint infection after receiving an injection for ankle pain.
For a map of cases by state, click here.
As many as 14,000 people may have been exposed to the suspect steroid, made by the New England Compounding Center in Framingham, Mass. Fifty sealed vials of the drug, obtained by the U.S. Food and Drug Administration, were found to contain fungus. The firm has recalled all of its products and shut down operations.
Seventy-six clinics in 23 states that received methylprednisolone acetate from the recalled lots have been instructed to notify all affected patients. The "potentially contaminated injections were given starting May 21, 2012," according to the CDC.
Forty-nine of the fungal meningitis cases -- six of them lethal -- have been reported in Tennessee. Cases have also been reported in Michigan, Virginia, Indiana, Maryland, Florida, Minnesota, North Carolina, Ohio, New Jersey and, most recently, Idaho.
Meningitis affects the membranous lining of the brain and spinal cord. Early symptoms of fungal meningitis, such as headache, fever, dizziness, nausea, sensitivity to light, stiff neck, weakness or numbness, slurred speech and pain, redness or swelling at the injection site can take more than a month to appear.
The longest duration from the time of injection to the onset of symptoms in the current outbreak is 42 days, according to the CDC's Dr. Benjamin Park.
"But we want to emphasize that we don't know what the longest will be," he said, adding that patients who received injections of the recalled drug should be wary of the subtle symptoms "for months."
Fungal meningitis is diagnosed through a lumbar puncture, which draws cerebrospinal fluid from the spine that can be inspected for signs of the disease. Once detected, it can be treated with high doses of intravenous antifungal medications.
People affected by the current outbreak are being treated with two different types of antifungal medications until the type of fungus causing the infection -- aspergillus or exserohilum -- can be identified.
"These drugs are very strong and can be very difficult for patients to tolerate over time," said Dr. J. Todd Weber, incident manager of the Multistate Meningitis Outbreak at the CDC, adding that the agency is working with experts on the dose and duration of the treatments.
The CDC has confirmed one case of aspergillus meningitis and 10 cases of exserohilum meningitis. It's unclear how the fungi landed in the steroid vials.
Unlike bacterial meningitis, fungal meningitis is not transmitted from person to person and only people who received the steroid injections are thought to be at risk.
The CDC also reported the possibility of joint infections, as methylprednisolone acetate is also used to treat ankle, knee and shoulder pain. One person in Michigan developed an infection after receiving an injection of the recalled steroid in the ankle, but CDC officials are still investigating the source of the infection.
"We may see additional patients coming in with infection of the joints," said Weber, adding that symptoms of fungal joint infections include fever and swelling, redness or pain at the injection site.
more info:

Toyota undaunted by latest massive global recall

Toyota executives were unfazed Thursday by the overnight recall of 7.43 million vehicles over faulty power window switches that can cause fires, calling it a sign the Japanese company had learned from its mistakes and was becoming quicker and more transparent.
TOKYO —
Toyota executives were unfazed Thursday by the overnight recall of 7.43 million vehicles over faulty power window switches that can cause fires, calling it a sign the Japanese company had learned from its mistakes and was becoming quicker and more transparent.
They said the models affected by the biggest single recall in Toyota Motor Corp.'s 75-year history were all made before global quality controls were beefed up in 2010. The change followed a series of massive recalls, mostly in the U.S., over sticky gas pedals, faulty floor mats and defective braking.
"We are not proud of recalls. But there is nothing wrong with recalls per se. Hiding anything would be the problem," Shigeru Hayakawa, a senior executive, told The Associated Press. "We are dealing with problems more expediently."
Hayakawa and other executives were at a gala event in Tokyo to launch the flagship Lexus LS luxury model. The recall was not mentioned anywhere in the formal presentation.
But the news of the massive recall cast a shadow over the festivities. The sheer size of the latest recall evoked memories of the fiasco in 2009 and 2010, which had prompted Toyota to pay $48.8 million in fines for its slow response.
Another problem was that Toyota initially said the window switch problem hadn't caused any injuries. But documents filed by U.S. safety regulators showed customers reported 161 fires and nine injuries. There have been no crashes or deaths.
Toyota spokesman Keisuke Kirimoto said the public relations division at headquarters that dealt with the recall announcement was not aware of the nine injuries reported at the U.S. National Highway Traffic Safety Administration. It was an embarrassing but honest error, he said.

NHTSA began looking into window switch problems with two Toyota models in February after noticing a higher than normal number of complaints. Most fires were minor, although one destroyed a Camry. Several owners reported that they were afraid to drive their vehicles because of the threat of fires. NHTSA said Wednesday the investigation remains open pending a review of recall documents.
The recall, spanning more than a dozen models sold around the world produced from 2005 through 2010, include the Camry, the top-selling car in the U.S. It's bigger than the 7 million vehicles recalled two years ago for floor mats that can trap accelerator pedals and cause unintended acceleration.
The new problem centers on the power window switch, which is inside the driver's door and controls when a window is opened or closed. Toyota said grease wasn't applied evenly to the switch during production, causing friction and sometimes smoke and fire.
The Toyota recall "takes some of the sheen off its recovering brand image and should have a financial impact," Standard & Poor's analyst Efraim Levy wrote in a note to investors. Toyota shares shed 1.3 percent in Tokyo trading.
Toyota said it did not know yet how much the latest recall would cost. But it was expected to be smaller than the 170 billion yen ($2 billion) to 180 billion yen ($2.2 billion) Toyota says it shouldered in recall costs for the accelerator, floor mat and brake problem in 2010.
Kiyotaka Ise, president of Lexus International, said the company was so intent on avoiding a repeat of the recall mess of two years ago it had held back rolling out models, including the LS, by several months.
That's why the Lexus model rollouts were coming out so quickly, one after the other, in recent months, and Toyota has channeled major resources into quality checks, he said.
"We are extremely sorry we have inconvenienced our customers," he said in an interview with the AP. "But we have been taking action to never repeat that kind of quality problem again."
Most of the complaints were about a sticky feel to the switches while pushing the button to raise or lower the window, but there also were complaints of the smell of smoke, according to Toyota. Using grease bought at a store to try to fix the problem had made the problem worse in some cases, it said.
The recall includes 2.5 million vehicles in the U.S., where it covers about half the models sold under the Toyota and Scion brands, but it spans all major regions, including Europe, Japan and the rest of Asia.
Analysts said it was too early to tell whether the latest recall would dent Toyota sales, which have been roaring back this year not only from the recall damage, but also from the tsunami and quake disaster last year in northeastern Japan, which had destroyed key suppliers and hobbled global production.
Toyota reclaimed the title of the world's top-selling automaker during the first half of this year, wresting the crown from General Motors Co. Toyota sold 4.97 million vehicles globally in the first half, beating GM by about 300,000.
---
AP Auto Writer Tom Krisher contributed to this report from Detroit.
Follow Yuri Kageyama on Twitter: http://www.twitter.com/yurikageyama

2012年10月7日星期日

Meningitis Cases Rise Amid Hunt for Victims


The number of people sickened with fungal meningitis from tainted epidural steroid injections has now risen to 91 in nine states, including seven deaths, federal officials said Sunday, as investigators try to home in on the precise source of contamination at a compounding pharmacy tied to the widespread outbreak.
Investigators from the U.S. Food and Drug Administration and state officials are probing the Framingham, Mass., facility where the New England Compounding Center made the 17,676 potentially tainted steroid injections, which were then shipped to 75 clinics in 23 states, according to federal and state officials.
A Centers for Disease Control and Prevention spokesman said it isn't possible to know how many cases there will be. The CDC and state health officials scrambled last week and over the weekend to track down patients who received the shots to see if they had been sick and to warn them to watch for possible symptoms.
The numbers of cases are rising sharply now not necessarily because people are continuing to get sick, but because investigators are pinpointing more illnesses among those who already received the injections of methylprednisolone acetate for relief of back and neck pain.
The injections were given between July and September. So far, those who have been infected developed symptoms between one and four weeks after receiving their injections.
"There's no evidence that new infections are occurring at a more rapid rate," said John Jernigan, medical epidemiologist at the CDC who is involved in the investigation.
It is too early to know how many people ultimately will be affected. Federal and state investigators must determine how many people received potentially contaminated injections, then track down each one. They must then confirm that those who have subsequently become ill actually had fungal meningitis and not another disease. There are "too many variables to speculate on the number of possible cases," said a CDC spokesman.
The compounding pharmacy that produced the injections in question issued a recall Saturday of all products made at its compounding center. "This action is being taken out of an abundance of caution due to the potential risk of contamination," the New England Compounding Center said in a statement. The company has said it is cooperating with investigators. It had no further comment Sunday.
The FDA had already advised medical professionals last week not to use NECC-made products.
Meningitis is a potentially deadly inflammation of the brain or central nervous system. It is usually caused by viruses or bacteria, but can also be brought on by fungi. The two fungi found thus far in some patients—known as aspergillus and exserohilum—are commonly found in the air and soil.
The fungal form of meningitis is particularly difficult to diagnose because the symptoms can be vague and mild initially, including fever, headache, nausea and stiffness of the neck, according to the CDC. People with fungal meningitis can also experience dizziness and confusion. Several of the patients in the current outbreak have had strokes.
Most of the people who have been sickened had normal immune systems, Dr. Jernigan said, meaning they weren't at particular risk of infections. While the investigation into how patients became infected is ongoing, there is some evidence to suggest that the fungi in the medication penetrated the lining protecting the central nervous system after being injected epidurally, Dr. Jernigan said.
While the fungi aren't harmful in the environment, they can become deadly when they flourish in a medication and are then injected directly into a part of the body that should not have germs, Dr. Jernigan said.
One possible victim, 56-year-old Tennessee resident Diana Reed, died Wednesday; she got meningitis after receiving steroid injections, says a lawyer for her family. She had received the injections at a facility that has since been closed because of a meningitis outbreak, according to its Web site.
Ms. Reed underwent an autopsy; the lawyer said he didn't yet know the results.
The outbreak has drawn renewed attention to the little-regulated world of compounding pharmacies. The FDA is hampered by federal law and conflicting federal court decisions over its authority to regulate compounding pharmacies. Current and former senior FDA officials said the agency has sought greater authority over the past decade, but so far has been stymied.
Government officials say the FDA is especially concerned about large compounding pharmacies that send out large amounts of drugs across the country—as opposed to a small pharmacy that may compound a medication three or four times a year.
In particular, the agency hasn't been able to take the normal steps it would take to ensure the safety of a drug produced at a compounding pharmacy. That includes requiring and evaluating clinical trials, and inspection of manufacturing facilities.
Attempts in the past by the agency to regulate more strenuously have been challenged in court.
Discount Donte Whitner Jersey,#20 Buffalo Bills Authentic Nfl Jersey In Blue

Syria, Turkey Trade Fire; Blast Hits Damascus Police

[image]

Turkish troops guard a border crossing in Akcakale, across from Syrian rebel-controlled Tel Abyad, on Sunday.
Syria and Turkey exchanged artillery fire for a fifth straight day on Sunday, while insurgents struck police headquarters in Damascus, in the third high-profile attack in the Syrian capital in recent weeks.
The escalating pressure in the capital and along the border present a rising pair of challenges for the Assad regime, which already accuses outside forces, including Turkey, of working with the rebels to destabilize the country.
A bomb in the Damascus police headquarters' parking lot caused the powerful blast that killed a police officer, said an official at the interior ministry.
In Turkey, there were no immediate reports of casualties in the early afternoon after a shell landed close to a grain-storage facility, witnesses said, several hundred yards from the town center in Akçakale, the border town where Syrian artillery killed five Turkish citizens on Wednesday.
Turkey's military fired artillery on targets inside Syria in response, Turkey's state-run news agency reported.
It has fired artillery shells across the border every day since Wednesday in response to Syrian artillery hitting towns along its border.
Syria's government, despite international condemnation, has held back from apologizing to Turkey while it investigates the source of the fire from its territory, which it says could be from antigovernment fighters who control large parts of the border territory.
U.S. Defense Secretary Leon Panetta warned over the weekend that the continued exchange of fire across the Syrian-Turkish border raises concerns that the conflict could spread to neighboring countries.
Mr. Panetta, in a news conference in Peru on Saturday, said that the U.S. is using its diplomatic channels to relay worries about the fighting, the Associated Press reported.
Still, regional diplomats and analysts say the risk of a full-blown confrontation between Syria and Turkey, former allies whose leaders were personal friends before Syria's crisis erupted last year, is limited.
Cross-border incidents are likely to continue, however, analysts say, as President Bashar al-Assad's forces pursue rebel fighters leading an insurgency against his rule.
"The risks of miscalculation are considerable," Ayham Kamel and Naz Masraff, analysts with political-risk firm Eurasia Group, wrote in a recent note.
"Ankara and Damascus no longer share a direct and open military or political communication channel. During potential clashes, miscommunication is probable and both sides could misinterpret their respective intentions," they wrote.
Mr. Assad can't afford to give up control of the border area, a lifeline for rebels, and has delegated military decision-making to local commanders, the analysts said. That raises the risk of knee-jerk responses and potential mistakes that could escalate, they added.
Turkey's leadership has made clear that it has no intention to go to war with Syria but that it would respond to violations of its sovereignty.
Turkish Prime Minister Recep Tayyip Erdogan has raised doubts over whether the frequent cross-border fire from Syria is an accident but has refrained from further comment on the Syrian government's intentions.
In Syria's al-Raqqa province, just across the border from Akçakale, rebel fighters said the source of the shelling on Sunday that struck Turkish territory was government tanks in the village of Ain Arous, about seven miles from the border.
The nearby city of Tal Abyad was still being shelled by Syrian army positions in the area, residents said.
Syrian rebels have voiced frustration with what they see as a restrained response from Turkey, but rejected accusations that they might be instigating border tensions to push Turkey toward an armed confrontation with Syrian regime forces of the sort that rebels have long advocated.
"The Free Syrian Army in Tal Abyad doesn't have tanks or missiles to launch these kind of attacks anyway," said Ayham al-Khalaf, an activist with the local activist media council in al-Raqqa.
In Damascus, security checkpoints cordoned off the Fahama district in the capital's center after the bombing occurred shortly after 7:15 p.m. local time.
A few reporters were later allowed into the compound where cleaning crews were sweeping up the debris and distraught members of the police force were comforting each other.
The facade of the two-story building was torn away and more than 20 vehicles were either incinerated or badly damaged. The stench of gasoline from ruptured fuel tanks filled the air.
Several police officers said a driver for one of the senior officers placed the bomb inside his boss's car, detonated it, and fled.
"He blew up the car and ran away to Deraa,"—the city in southern Syria where antigovernment protests first erupted last year—said a young officer with a bandaged arm and blood-covered T-shirt.
The bombing is the latest in a string of apparent rebel victories in the heart of Damascus, signaling how precarious security has become in the once-calm capital even as fighting between government and rebel forces has been focused farther north in Aleppo.
Sunday's attack came after several bombings last week in Aleppo that appeared to target hotels housing military officers, and blasts that rocked the headquarters of the armed forces in central Damascus on Sept. 26.
Police chief Maj. Gen. Ibrahim Ibrahim sat on a lawn chair at the scene of the blast in Damascus but refused to speak to the media.
An hour after the first explosion, two other explosions were heard in the city, but their cause wasn't immediately known.

Neuve Chaussure Nike France Air Force One Noir Rouge Blanc Bon Prix
Cheap Staubach Jersey,Throwback #12 Dallas Cowboys Authentic Nfl Jersey In White